Brca1/2 Gene Mutations Detection Kit（next Generation Sequencing）

DETECTION SIGNIFICANCE

1.Predict therapeutic efficacy of PARP inhibitors in patients with cancers such as ovarian cancer, breast cancer, prostate cancer ， pancreatic cancer , etc.

2.Facilitate the diagnosis of hereditary cancer syndromes, including hereditary breast-ovarian cancer syndrome (HBOC) and hereditary prostate cancer.

FEATURES & ADVANTAGES

1.Simple Operation: Utilizing the patented RingCap® technology and pre-packaged reagents in 8-tube strips, the library preparation process is simplified, enabling shorter trun around time.

2.High Sensitivity: Detect gene mutations as low as 1% in 25ng DNA samples.

3.Comprehensive Coverage: Since there are no high-frequency mutation hotspots in the BRCA1/2 genes, sequencing of both the coding regions and adjacent boundary regions ensures comprehensive coverage in the testing process.

4.Rigorous and professional: Comprehensive and strict quality control standards, automated analysis + double verification by a professional team, truly achieving comprehensive and accurate interpretation.